Report Detail
Global Rivaroxaban Market Growth 2019-2024
- RnM2881714 |
- 05 February, 2019 |
- Global |
- 130 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceutica. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects last approximately 8–12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.
The global average price of Rivaroxaban is in the decreasing trend, from 5.62 USD/Unit in 2011 to 5.34 USD/Unit in 2015. With the situation of global economy, prices will be in slowly decreasing trend in the following five years.
Bayer is the only supplier of Rivaroxaban enjoying production market share100% in 2015 and it will still in this situation until 2023.
According to this study, over the next five years the Rivaroxaban market will register a 9.4% CAGR in terms of revenue, the global market size will reach US$ 10100 million by 2024, from US$ 5860 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Rivaroxaban business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Rivaroxaban market by product type, application, key manufacturers and key regions and countries.
This study considers the Rivaroxaban value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
2.5 mg
10 mg
15 mg
20 mg
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Acute Coronary Syndrome (ACS)
Venous Thromboembolism (VTE)
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bayer
J&J
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Rivaroxaban consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Rivaroxaban market by identifying its various subsegments.
Focuses on the key global Rivaroxaban manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Rivaroxaban with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Rivaroxaban submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Rivaroxaban Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Rivaroxaban Consumption 2014-2024
- 2.1.2 Rivaroxaban Consumption CAGR by Region
- 2.2 Rivaroxaban Segment by Type
- 2.2.1 2.5 mg
- 2.2.2 10 mg
- 2.2.3 15 mg
- 2.2.4 20 mg
- 2.3 Rivaroxaban Consumption by Type
- 2.3.1 Global Rivaroxaban Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Rivaroxaban Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Rivaroxaban Sale Price by Type (2014-2019)
- 2.4 Rivaroxaban Segment by Application
- 2.4.1 Acute Coronary Syndrome (ACS)
- 2.4.2 Venous Thromboembolism (VTE)
- 2.5 Rivaroxaban Consumption by Application
- 2.5.1 Global Rivaroxaban Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Rivaroxaban Value and Market Share by Application (2014-2019)
- 2.5.3 Global Rivaroxaban Sale Price by Application (2014-2019)
3 Global Rivaroxaban by Players
- 3.1 Global Rivaroxaban Sales Market Share by Players
- 3.1.1 Global Rivaroxaban Sales by Players (2017-2019)
- 3.1.2 Global Rivaroxaban Sales Market Share by Players (2017-2019)
- 3.2 Global Rivaroxaban Revenue Market Share by Players
- 3.2.1 Global Rivaroxaban Revenue by Players (2017-2019)
- 3.2.2 Global Rivaroxaban Revenue Market Share by Players (2017-2019)
- 3.3 Global Rivaroxaban Sale Price by Players
- 3.4 Global Rivaroxaban Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Rivaroxaban Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Rivaroxaban Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Rivaroxaban by Regions
- 4.1 Rivaroxaban by Regions
- 4.1.1 Global Rivaroxaban Consumption by Regions
- 4.1.2 Global Rivaroxaban Value by Regions
- 4.2 Americas Rivaroxaban Consumption Growth
- 4.3 APAC Rivaroxaban Consumption Growth
- 4.4 Europe Rivaroxaban Consumption Growth
- 4.5 Middle East & Africa Rivaroxaban Consumption Growth
5 Americas
- 5.1 Americas Rivaroxaban Consumption by Countries
- 5.1.1 Americas Rivaroxaban Consumption by Countries (2014-2019)
- 5.1.2 Americas Rivaroxaban Value by Countries (2014-2019)
- 5.2 Americas Rivaroxaban Consumption by Type
- 5.3 Americas Rivaroxaban Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Rivaroxaban Consumption by Countries
- 6.1.1 APAC Rivaroxaban Consumption by Countries (2014-2019)
- 6.1.2 APAC Rivaroxaban Value by Countries (2014-2019)
- 6.2 APAC Rivaroxaban Consumption by Type
- 6.3 APAC Rivaroxaban Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Rivaroxaban by Countries
- 7.1.1 Europe Rivaroxaban Consumption by Countries (2014-2019)
- 7.1.2 Europe Rivaroxaban Value by Countries (2014-2019)
- 7.2 Europe Rivaroxaban Consumption by Type
- 7.3 Europe Rivaroxaban Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Rivaroxaban by Countries
- 8.1.1 Middle East & Africa Rivaroxaban Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Rivaroxaban Value by Countries (2014-2019)
- 8.2 Middle East & Africa Rivaroxaban Consumption by Type
- 8.3 Middle East & Africa Rivaroxaban Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Rivaroxaban Distributors
- 10.3 Rivaroxaban Customer
11 Global Rivaroxaban Market Forecast
- 11.1 Global Rivaroxaban Consumption Forecast (2019-2024)
- 11.2 Global Rivaroxaban Forecast by Regions
- 11.2.1 Global Rivaroxaban Forecast by Regions (2019-2024)
- 11.2.2 Global Rivaroxaban Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Rivaroxaban Forecast by Type
- 11.8 Global Rivaroxaban Forecast by Application
12 Key Players Analysis
- 12.1 Bayer
- 12.1.1 Company Details
- 12.1.2 Rivaroxaban Product Offered
- 12.1.3 Bayer Rivaroxaban Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Bayer News
- 12.2 J&J
- 12.2.1 Company Details
- 12.2.2 Rivaroxaban Product Offered
- 12.2.3 J&J Rivaroxaban Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 J&J News
...
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Rivaroxaban . Industry analysis & Market Report on Rivaroxaban is a syndicated market report, published as Global Rivaroxaban Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Rivaroxaban market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
